Clinical Trial Update: A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III randomized trial evaluating concurrent chemoradiotherapy with or without TNF for nasopharyngeal carcinoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• TNF-α (tumor necrosis factor alpha)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, TNF | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING